To this end, we observed that BMPER plasma level was reduced by ~50% in humans with metabolic syndrome (MS)25, a complication often coupled with insulin resistance and increased risk for T2DM26, compared to healthy individuals (Fig. 3a, b). This evidence concerns the gene BMPER and metabolic syndrome.